Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Thaler

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|October 26, 2021
CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune EncephalitisMarc Dürr, Gunnar Nissen, Kurt-Wolfram Sühs, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 PandemicJonathan Wickel, Ha-Yeun Chung, Franz Felix Konen, et al.
Acta Neuropathologica Communications|December 1, 2020
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNSRamona Gerhards, Lena Kristina Pfeffer, Jessica Lorenz, et al.
Journal of the Neurological Sciences|January 7, 2023
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy responseMarie Madlener, Christine Strippel, Franziska S Thaler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026
Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophyLisa Tagnin, Julia S Dorneich, Marianthi Zeinaki, et al.
Nature Genetics|December 4, 2023
Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseasesMax Homilius, Wandi Zhu, Samuel S Eddy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Brain : a Journal of Neurology|March 8, 2022
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Neurology(R) Neuroimmunology & Neuroinflammation|October 26, 2021
CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune EncephalitisMarc Dürr, Gunnar Nissen, Kurt-Wolfram Sühs, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 PandemicJonathan Wickel, Ha-Yeun Chung, Franz Felix Konen, et al.
Acta Neuropathologica Communications|December 1, 2020
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNSRamona Gerhards, Lena Kristina Pfeffer, Jessica Lorenz, et al.
Journal of the Neurological Sciences|January 7, 2023
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy responseMarie Madlener, Christine Strippel, Franziska S Thaler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026
Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophyLisa Tagnin, Julia S Dorneich, Marianthi Zeinaki, et al.
Nature Genetics|December 4, 2023
Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseasesMax Homilius, Wandi Zhu, Samuel S Eddy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.
Brain : a Journal of Neurology|March 8, 2022
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.
Pageof 23